Demoly P, Jaffuel D, Godard P, Michel F B, Bousquet J
INSERM U454, IFR3, Hôpital Arnaud de Villeneuve, CHU de Montpellier.
Presse Med. 2000 Oct 7;29(29):1625-9.
Many pregnant women have asthma and/or rhinitis. Particular attention is required when prescribing drugs in this situation. Medication can be prescribed during pregnancy when the apparent benefit is greater than the apparent risk. Usually at least one drug of each major class used to control these disease can be given safely. In addition, physiological changes associated with pregnancy could affect the upper and lower pathways. CAREFUL MANAGEMENT: Ideally, drug prescription for asthma and/or rhinitis in pregnant women should be part of a global process implicating obstetricians, primary care physicians, and allergy, rhinology or lung specialists. The only way to improve the mother's comfort and avoid complications for both mother and child is to perfectly control the disease. Indeed, it would be regrettable to be too prudent and deprive symptomatic patients of active treatments. Patients should be clearly informed of the benefits and risks of drug therapy.
许多孕妇患有哮喘和/或鼻炎。在这种情况下开药时需要特别注意。当明显益处大于明显风险时，孕期可以开药。通常用于控制这些疾病的每个主要类别中至少有一种药物可以安全使用。此外，与怀孕相关的生理变化可能会影响上下呼吸道。
理想情况下，孕妇哮喘和/或鼻炎的药物处方应作为一个涉及产科医生、初级保健医生以及过敏、鼻科或肺部专家的全面过程的一部分。改善母亲舒适度并避免母婴并发症的唯一方法是完美控制疾病。确实，过于谨慎而剥夺有症状患者的积极治疗是令人遗憾的。应向患者清楚告知药物治疗的益处和风险。
